Letter to the Editor

Cytisine as an Emerging Tool for Smoking Cessation and Addiction Treatment

Abstract

No Abstract. Not abstract.

utka P, Vinnikov D, Courtney RJ, Benowitz NL (2019). Cytisine for nicotine addiction treatment: a review of pharmacology, therapeutics and an up-date of clinical trial evidence for smoking cessation. Addiction, 114(11):1951-69.
2. Walker N, Howe C, Glover M, et al (2014). Cytisine ver-sus nicotine for smoking cessation. N Engl J Med, 371(25):2353-62.
3. Courtney RJ, McRobbie H, Tutka P, et al (2021). Effect of cytisine vs varenicline on smoking cessation: a randomized clinical trial. JAMA, 326(1):56-64.
4. Walker N, Smith B, Barnes J, et al (2021). Cytisine versus varenicline for smoking cessation in New Zealand indigenous Māori: a randomized controlled trial. Addiction, 116(10):2847-58.
5. Phusahat P, Dilokthornsakul P, Boonsawat W, et al (2022). Efficacy and Safety of Cytisine in Combina-tion with a Community Pharmacists’ Counselling for Smoking Cessation in Thailand: A Random-ized Double-Blinded Placebo-Controlled Trial. Int J Environ Res Public Health, 19(20):13358.
6. Rigotti NA, Benowitz NL, Prochaska J, et al (2023). Cyt-isinicline for Smoking Cessation: A Randomized Clinical Trial. JAMA, 330(2):152–60.
7. Campagnari S, Casari R, Zamboni L, et al (2022). Cytis-ine induced urticaria: a case report during a smok-ing cessation treatment. Acta Biomed, 93(S1):e2022073.
8. Zatonski W, Cedzynska M, Tutka P, et al (2006). An un-controlled trial of cytisine (Tabex) for smoking ces-sation. Tobacco Control, 15(6):481-4.
Files
IssueVol 53 No 12 (2024) QRcode
SectionLetter to the Editor

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Güler Sönmez T, Fidancı İzzet. Cytisine as an Emerging Tool for Smoking Cessation and Addiction Treatment. Iran J Public Health. 2024;53(12):2823-2824.